4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia , inhibits severe acute respiratory syndrome coronavirus ( SARS-CoV ) papain-like protease ( PLpro ) activity, with an IC 50 of 10.1 μMForm:SolidIC50& Target:IC50: 10.1 μM
4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia , inhibits severe acute respiratory syndrome coronavirus ( SARS-CoV ) papain-like protease ( PLpro ) activity, with an IC 50 of 10.1 μMForm:SolidIC50& Target:IC50: 10.1 μM
4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia , inhibits severe acute respiratory syndrome coronavirus ( SARS-CoV ) papain-like protease ( PLpro ) activity, with an IC 50 of 10.1 μMForm:SolidIC50& Target:IC50: 10.1 μM
4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia , inhibits severe acute respiratory syndrome coronavirus ( SARS-CoV ) papain-like protease ( PLpro ) activity, with an IC 50 of 10.1 μMForm:SolidIC50& Target:IC50: 10.1 μM
4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia , inhibits severe acute respiratory syndrome coronavirus ( SARS-CoV ) papain-like protease ( PLpro ) activity, with an IC 50 of 10.1 μMForm:SolidIC50& Target:IC50: 10.1 μM
4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia , inhibits severe acute respiratory syndrome coronavirus ( SARS-CoV ) papain-like protease ( PLpro ) activity, with an IC 50 of 10.1 μMForm:SolidIC50& Target:IC50: 10.1 μM
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells.In Vitro:Anti-SARS-80R mAb against SARS-CoV
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells.In Vitro:Anti-SARS-80R mAb against SARS-CoV
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells.In Vitro:Anti-SARS-80R mAb against SARS-CoV
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells.In Vitro:Anti-SARS-80R mAb against SARS-CoV
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein.Appearance:LiquidIn Vitro:CR3022 recognizes a cryptic epitope that is only accessible when S
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein.Appearance:LiquidIn Vitro:CR3022 recognizes a cryptic epitope that is only accessible when S
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein.Appearance:LiquidIn Vitro:CR3022 recognizes a cryptic epitope that is only accessible when S
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein.Appearance:LiquidIn Vitro:CR3022 recognizes a cryptic epitope that is only accessible when S
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment.Appearance:LiquidBiological
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment.Appearance:LiquidBiological
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment.Appearance:LiquidBiological
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment.Appearance:LiquidBiological
AT-9010 tetrasodium, a triphosphate active metabolite of AT-527, is a potent inhibitor of NiRAN (a function essential for viral replication). AT-9010 tetrasodium can inhibit SARS-CoV-2 replicationIn VitroSubstantial levels of the active triphosphate
AT-9010 tetrasodium, a triphosphate active metabolite of AT-527, is a potent inhibitor of NiRAN (a function essential for viral replication). AT-9010 tetrasodium can inhibit SARS-CoV-2 replicationIn VitroSubstantial levels of the active triphosphate